Diagnos Inc.
DGNOF
$0.189
-$0.0047-2.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -48.63% | -40.68% | -35.90% | -42.66% | -57.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -48.63% | -40.68% | -35.90% | -42.66% | -57.62% |
| Cost of Revenue | 38.88% | 0.41% | 4.24% | 10.60% | 18.81% |
| Gross Profit | -57.79% | -8.74% | -14.80% | -34.74% | -94.93% |
| SG&A Expenses | 65.17% | 56.97% | 24.96% | 13.35% | -2.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.24% | 36.44% | 17.91% | 12.45% | 3.77% |
| Operating Income | -62.97% | -41.47% | -22.02% | -18.71% | -14.44% |
| Income Before Tax | -47.09% | -32.65% | -21.50% | -21.11% | -21.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.09% | -32.65% | -21.50% | -21.11% | -21.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.09% | -32.65% | -21.50% | -21.11% | -21.38% |
| EBIT | -62.97% | -41.47% | -22.02% | -18.71% | -14.44% |
| EBITDA | -65.65% | -43.07% | -22.91% | -18.84% | -14.47% |
| EPS Basic | -16.34% | -8.18% | -4.76% | -11.11% | -14.18% |
| Normalized Basic EPS | -16.75% | -9.09% | -5.61% | -11.73% | -14.37% |
| EPS Diluted | -16.34% | -8.18% | -4.76% | -11.11% | -14.18% |
| Normalized Diluted EPS | -16.75% | -9.09% | -5.61% | -11.73% | -14.37% |
| Average Basic Shares Outstanding | 26.42% | 21.17% | 14.85% | 8.94% | 6.42% |
| Average Diluted Shares Outstanding | 26.42% | 21.17% | 14.85% | 8.94% | 6.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |